Greenphire expands ConneX patient service solution

By Jenni Spinner

- Last updated on GMT

(Image: Getty/monkeybusinessimages)
(Image: Getty/monkeybusinessimages)

Related tags Clinical trials COVID-19 Greenphire Coronavirus

The company’s ConneX Patient Direct service enables transport of trial medications, equipment and healthcare professionals directly to participants.

The Patient Direct service is designed to enable sites and sponsors to continue trials in the face of disruptive events, such as the current COVID-19 pandemic. It enables ‘clean’ transport for needed medications, medical equipment and staff for treatment and monitoring.

The US Food and Drug Administration (FDA) and European Medicines Agency (EMA) both have issued guidelines for conducting clinical trials during the spread of the virus. The guidelines empower sponsors to explore alternative methods and ways to ensure the continued safety of participants and staff.

Continuing trials

Jim Murphy, Greenphire CEO, told Outsourcing-Pharma that the existing ConneX patient travel service served trials well, in enabling transport of patients to a clinic for trial activity, then safely back home. The COVID-19 pandemic, however, disrupted the typical flow of participants.

As the pandemic spread, it became very clear that medically fragile patients were unable to go to clinical trial sites​,” he told us. "Through conversations with sponsors and sites, as well as in our 1,800+ person site survey and recent FDA/EMA guidance, it was clear that new stresses have emerged, and that existing travel patterns and services don’t meet the needs of today’s challenging environment​.”

Site survey

The company developed the Patient Direct service in response to the survey, which polled site personnel across the globe on the impact of COVID-19. Findings of the survey include:

  • 69% of survey respondents are using technology to support at-home patient care.
  • 60% would use a service that would transport medical equipment and/or medicine to the patient’s home.
  • Almost 48% would find a service that would facilitate the travel of site personnel to patients’ homes to conduct regularly scheduled visits useful.
  • Nearly 55% are open to patients going to an alternative, closer facility for tests or visits in an effort to keep the patients in the trial.

Additionally, one respondent, when asked what their site was doing to help meet patient needs, indicated staff were conducting telephone monitoring, medical accompaniment of the research subjects, and traveling to participant homes to collect samples and deliver medication.

I live nearby an elder patient and did not want them to travel by bus because of potential contact with infected commuters​,” the respondent indicated. “I transported the patient in my car​.”

Addressing concerns

Murphy told us the ConneX Patient Direct service helps address the needs and concerns expressed by site personnel by making it possible to safely send medicines, equipment and site team members to participants’ residences.

This globally available service can also support traditional visit flows involving patients traveling to the clinic but does so using medical grade clean ground transportation​,” he said. “This new flow of travel keeps the patient, site and study on-track by ensuring treatments are available to the patients who depend on them​.”

Murphy indicated Patient Direct is a permanent addition to the ConneX service suite. He added such direct-to-patient services can serve as an effective addition to decentralized trials and telemedicine trial programs.

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Related suppliers

Follow us


View more